Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to determine whether starting metformin in conjunction
with a second-generation antipsychotic (SGA) and providing information about healthy eating
and activity will prevent or reduce the amount of weight gain and the metabolic changes in
adolescent youth typically seen with second-generation antipsychotic medication.